[The antirelapse effectiveness of amyxin used in combination with antiherpetic vaccine in patients with herpetic keratitis].
The efficiency of the combined use of amixin and anti-herpetic vaccination (AHV) to prevent the relapses of herpetic keratitis (HK) is investigated. One hundred and four patients with HK were followed up. The efficiency was found to be higher in the group of patients who received both amixin and AHV: in 29 (87.9%) patients with surface HK and in 10 (90.9%) patients with deep HK. No effect was registered in 4 (12.1%) persons with surface HK and in 1 (9.1%) person with deep HK. Amixin, when combined with AHV, cuts the number of relapses, therefore, it extends the remission period. The suggested scheme of amixin administration is as follow: 125 mg, once per week, for 10 weeks, 10 pills per one treatment course.
Moshetova
L K
LK
Chernakova
G M
GM
Abaeva
M R
MR
D000328:Adult; D000367:Age Factors; D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D022301:Herpes Simplex Virus Vaccines / Q000008:administration & dosage*; D006801:Humans; D016233:Immunotherapy, Active; D016849:Keratitis, Herpetic / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D012008:Recurrence; D012737:Sex Factors; D013994:Tilorone / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D022301:Herpes Simplex Virus Vaccines; D013994:Tilorone